AITRICS, a healthcare artificial intelligence (AI) company, has unveiled AITRICS-VC (VitalCare), an AI solution for predicting patient deterioration, at major medical device exhibitions in Korea and the United States.

AITRICS said Monday that it participated in the HIMSS 2024 Global Health Exhibition in Orlando, Fla., from March 11 to 15. HIMSS is the world's largest healthcare IT show, and it is organized by the U.S. Healthcare Information and Management Systems Society.

VitalCare is AI software that predicts acute critical events, such as death, ICU admission, cardiac arrest, within six hours in a general ward, sepsis within four hours in a general ward, and the probability of death within six hours in an ICU.

VitalCare entered the non-reimbursement market in March 2023 under a moratorium on new medical technology evaluation by the Ministry of Health and Welfare. It is used in about 40 hospitals in Korea, including Gangnam Severance Hospital, Korea University Anam Hospital, and Korea University Guro Hospital.

At its promotional booth, AITRICS let visitors experience VitalCare firsthand and explained its clinical use experience in Korea. Last December, the company established a U.S. office to expand its overseas presence further.

The company also participated in the Korea International Medical and Hospital Equipment Show (KIMES) 2024 at COEX, southern Seoul, from March 14 to 17. On the first day of the event, Ahn Byung-eun, AITRICS's chief strategy officer (CSO), presented at the Innovation Industry Committee seminar on “Development and Clinical Adoption of Vital Signs AI Medical Devices.”

"It was meaningful to participate in the HIMSS exhibition for the third consecutive year since 2022 and share the excellence of VitalCare and various achievements in Korea to lay the foundation for our entry into the U.S. market," said AIRICS CEO Kim Kwang-jun, also a professor of geriatrics at Severance Hospital.

"We are organizing a team to secure data and prepare for U.S. clinical trials. We will strive to make VitalCare widely available in medical centers worldwide and provide practical help to patients and physicians beyond Korea."